BIOHLDG Stock Overview
An investment holding company, researches, develops, manufactures, imports, exports, trades in, and distributes nutritional and healthcare products in Malaysia, China, Indonesia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Bioalpha Holdings Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.065 |
| 52 Week High | RM 0.14 |
| 52 Week Low | RM 0.05 |
| Beta | 2.21 |
| 1 Month Change | -7.14% |
| 3 Month Change | -13.33% |
| 1 Year Change | -38.10% |
| 3 Year Change | -65.79% |
| 5 Year Change | -64.86% |
| Change since IPO | -67.52% |
Recent News & Updates
Recent updates
Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?
Mar 19
Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?
Oct 04Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?
Jun 20Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely
Mar 01Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching
Mar 29Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?
Mar 03Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?
Jan 20
How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?
Nov 28Shareholder Returns
| BIOHLDG | MY Personal Products | MY Market | |
|---|---|---|---|
| 7D | 0% | -0.9% | -1.0% |
| 1Y | -38.1% | -13.3% | 10.0% |
Return vs Industry: BIOHLDG underperformed the MY Personal Products industry which returned -13.3% over the past year.
Return vs Market: BIOHLDG underperformed the MY Market which returned 10% over the past year.
Price Volatility
| BIOHLDG volatility | |
|---|---|
| BIOHLDG Average Weekly Movement | 12.2% |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in MY Market | 10.5% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: BIOHLDG's share price has been volatile over the past 3 months compared to the MY market.
Volatility Over Time: BIOHLDG's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of MY stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | William Hon | bioa.com.my |
Bioalpha Holdings Berhad, an investment holding company, researches, develops, manufactures, imports, exports, trades in, and distributes nutritional and healthcare products in Malaysia, China, Indonesia, and internationally. It operates through Trading, Manufacturing, Retail Pharmacy, and Others segments. The company engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export, cultivation, manufacturing, distribution, and trading of various agro products and medical herbs; and planting, growing, and trading of herbs, fruits, agricultural, and agro and organic products.
Bioalpha Holdings Berhad Fundamentals Summary
| BIOHLDG fundamental statistics | |
|---|---|
| Market cap | RM 91.42m |
| Earnings (TTM) | -RM 39.17m |
| Revenue (TTM) | RM 82.49m |
1.1x
P/S Ratio-2.3x
P/E RatioIs BIOHLDG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOHLDG income statement (TTM) | |
|---|---|
| Revenue | RM 82.49m |
| Cost of Revenue | RM 81.33m |
| Gross Profit | RM 1.16m |
| Other Expenses | RM 40.33m |
| Earnings | -RM 39.17m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.028 |
| Gross Margin | 1.41% |
| Net Profit Margin | -47.49% |
| Debt/Equity Ratio | 2.2% |
How did BIOHLDG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 22:00 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioalpha Holdings Berhad is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lee Fang Ng | CGS International |
| Michael Kokalari | Maybank Research Pte. Ltd. |
| Sze Tee | Maybank Research Pte. Ltd. |